We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.52B
AUM Growth
+$6.76M
Cap. Flow
+$42.3M
Cap. Flow %
2.79%
Top 10 Hldgs %
27.44%
Holding
435
New
29
Increased
184
Reduced
112
Closed
75

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
+$21.1M
2
FSLR icon
First Solar
FSLR
+$15.7M
3
UTHR icon
United Therapeutics
UTHR
+$14.9M
4
HUM icon
Humana
HUM
+$14.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.4M

Top Sells

1
KMB icon
Kimberly-Clark
KMB
+$17M
2
ED icon
Consolidated Edison
ED
+$12.7M
3
EOG icon
EOG Resources
EOG
+$10.4M
4
ES icon
Eversource Energy
ES
+$9.97M
5
DGX icon
Quest Diagnostics
DGX
+$9.72M

Sector Composition

1 Healthcare 33.75%
2 Consumer Staples 26.59%
3 Technology 8.26%
4 Communication Services 7.04%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RY icon
176
Royal Bank of Canada
RY
$299B
$277K 0.02%
2,912
– –
PSA icon
177
Public Storage
PSA
$55.9B
$272K 0.02%
899
+110
+14% +$32.3K
CINF icon
178
Cincinnati Financial
CINF
$27.8B
$265K 0.02%
2,364
+302
+15% +$34.4K
ROP icon
179
Roper Technologies
ROP
$36.7B
$263K 0.02%
597
– –
CMG icon
180
Chipotle Mexican Grill
CMG
$44.5B
$261K 0.02%
7,650
– –
MAR icon
181
Marriott International
MAR
$96.2B
$261K 0.02%
1,572
– –
CDNS icon
182
Cadence Design Systems
CDNS
$90.2B
$259K 0.02%
1,233
+176
+17% +$33.3K
SNPS icon
183
Synopsys
SNPS
$71.8B
$258K 0.02%
669
+173
+35% +$61.8K
MSTR icon
184
Strategy Inc
MSTR
$34.1B
$254K 0.02%
8,680
+3,220
+59% +$78.6K
DXCM icon
185
DexCom
DXCM
$29.5B
$251K 0.02%
2,159
+1,246
+136% +$139K
INCY icon
186
Incyte
INCY
$23.5B
$250K 0.02%
3,456
+2,038
+144% +$159K
PCG icon
187
PG&E
PCG
$38.1B
$249K 0.02%
15,397
-9,523
-38% -$150K
A icon
188
Agilent Technologies
A
$37.1B
$247K 0.02%
1,788
+239
+15% +$34.9K
MNST icon
189
Monster Beverage
MNST
$95.2B
$247K 0.02%
4,566
+628
+16% +$32.2K
ANET icon
190
Arista Networks
ANET
$211B
$242K 0.02%
5,760
– –
VTR icon
191
Ventas
VTR
$46.8B
$239K 0.02%
5,524
+711
+15% +$34.3K
CNC icon
192
Centene
CNC
$32.7B
$237K 0.02%
3,746
+519
+16% +$36.8K
WPC icon
193
W.P. Carey
WPC
$16.8B
$237K 0.02%
3,126
+1,877
+150% +$150K
LULU icon
194
lululemon athletica
LULU
$13.2B
$235K 0.02%
645
+548
+565% +$172K
ERF
195
DELISTED
Enerplus Corporation
ERF
$235K 0.02%
16,362
-20,615
-56% -$332K
GLW icon
196
Corning
GLW
$133B
$234K 0.02%
6,635
+1,969
+42% +$68.5K
ILMN icon
197
Illumina
ILMN
$28.1B
$234K 0.02%
1,035
+149
+17% +$30.5K
TFC icon
198
Truist Financial
TFC
$65.6B
$234K 0.02%
6,867
– –
YUM icon
199
Yum! Brands
YUM
$41.1B
$234K 0.02%
1,770
+254
+17% +$32.7K
AFL icon
200
Aflac
AFL
$63.5B
$227K 0.02%
3,519
+530
+18% +$36.3K
6 7
8
9 10

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q1 2023 Portfolio in Review

As of Q1 2023, TOBAM held 435 positions worth $1.52B, up 0.45% from $1.51B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM's Q1 2023 filing shows 29 new, 184 increased, 112 reduced and 75 closed positions. Its largest new stake was Bausch Health: 308,486 shares worth $2.49M. The largest sale was Kimberly-Clark, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.

  • TOBAM's largest Q1 2023 buy was Bausch Health: 308,486 shares worth $2.49M.
  • TOBAM added most to Bristol-Myers Squibb in Q1 2023, an estimated $21.1M increase.
  • TOBAM's biggest Q1 2023 reduction was Kimberly-Clark, cutting an estimated $17M.
  • TOBAM fully exited Stantec in Q1 2023, selling an estimated $1.26M.
  • TOBAM's ten largest holdings make up 27% of its $1.52B portfolio in Q1 2023.
  • TOBAM opened 29 new positions and closed 75 in Q1 2023.
  • TOBAM's portfolio value rose 0.45% quarter-over-quarter to $1.52B.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.